International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 3 : 1013-1017
Research Article
A Retrospective Assessment of the Occurrence of Congenital Anomalies in Intrauterine Foetus of 20–24 Weeks of Pregnancy: A Hospital-Based Study
 ,
 ,
Received
March 20, 2026
Accepted
April 16, 2026
Published
May 22, 2026
Abstract

Background: Congenital anomalies are an important cause of perinatal and neonatal mortality and long-term morbidity, particularly in developing countries. Early detection during the second trimester is crucial for counselling and management. The present study was undertaken to assess the occurrence of congenital anomalies in intrauterine foetuses of 20–24 weeks of gestation.

Aim: To assess the occurrence and pattern of congenital anomalies in intrauterine foetuses of 20–24 weeks of pregnancy and to evaluate the associated maternal risk factors.

Materials and Methods: This was a retrospective, analytical, hospital-based study of patients who delivered or aborted a congenitally anomalous baby. During the study period, 50 congenital anomalies were identified among delivered babies and aborted foetuses. Relevant demographic, obstetric and clinical information was documented and analysed.

Results: Of the 50 patients, 37 (74%) were aged 20–29 years and 12 (24%) were >30 years; 18 (36%) were primigravida. Thirty-nine (78%) patients belonged to a rural area and 32 (64%) were unbooked. Antenatal ultrasonography detected anomalies in 35 (70%) patients, while 15 (30%) had not undergone an antenatal scan. Sixteen (32%) patients underwent lower segment caesarean section (LSCS) and 18 (36%) were preterm. The principal associated maternal risk factors were anaemia (30%), polyhydramnios (20%), previous caesarean section (20%), oligohydramnios (16%), pregnancy-induced hypertension (16%), twins (10%), breech presentation (10%), intrauterine growth restriction (10%) and Rh-negative status (10%).

Conclusion: Congenital anomalies were more common among rural, unbooked patients and were associated with a higher rate of stillbirth and preterm delivery. Early diagnosis through routine antenatal ultrasonography and appropriate genetic counselling for the index and subsequent pregnancies are essential for the proper management of this important public health problem.

Keywords
INTRODUCTION

The term “congenital” denotes a condition that is present at birth. Congenital malformation refers to errors in morphogenesis occurring during early foetal development¹ and is characterised as physical, metabolic or anatomical abnormalities that may be detected before birth, at birth or during the first year of life.² Congenital abnormalities make a significant contribution to foetal and neonatal mortality and impairment globally³, accounting for 8–15% of perinatal deaths and 13–16% of newborn deaths in India.⁴,⁵ Perinatal mortality is one of the most sensitive indicators of the quality of maternal and neonatal care. In recent years, congenital diseases have emerged as a major public health problem in developing nations, attributable to a relative decline in deaths from infections and malnutrition and a corresponding rise in morbidity and mortality from congenital anomalies.

 

Ultrasound is a crucial diagnostic tool for the identification of numerous developmental abnormalities. The initial diagnostic ultrasound screening is generally conducted between 11 and 13 weeks of gestation, during which nuchal translucency thickness is assessed and the presence of the nasal bone is verified.⁸,⁹ Birth defects (BDs) or congenital anomalies are defined as anatomical or functional abnormalities, including metabolic disorders, that arise during intrauterine development—predominantly within the first trimester of gestation.¹⁰⁻¹² The World Health Organization (WHO) reports that BDs are among the leading contributors to spontaneous abortion, stillbirth and mortality and impairment in children under five years of age. Approximately 3–6% of newborns are born with severe birth defects, and over 3.3 million children succumb to birth defects globally each year.¹³,¹⁴

 

Anomaly scans have become standard practice during the prenatal period, with the optimal time for detection being approximately 18 weeks of gestation. Some defects may, however, evade detection by conventional ultrasonography and necessitate a foetal autopsy to identify accompanying anomalies and confirm the diagnosis. This aids in identifying the cause of foetal loss and is therefore an important component of subsequent genetic counselling.¹⁵ Central nervous system (CNS) abnormalities are among the most prevalent categories of congenital malformations.¹⁶,¹⁷ A considerable proportion of congenital defects cannot be identified on prenatal assessments such as ultrasonography alone, necessitating autopsy.¹⁸ Foetal autopsy is commonly indicated in cases of congenital abnormality, intrauterine foetal demise and inevitable abortion.¹⁹

 

The objective of the present study was to evaluate the prevalence and pattern of congenital abnormalities in intrauterine foetuses at 20–24 weeks of gestation in a tertiary care setting.

 

MATERIALS AND METHODS

Study design and setting: This was a retrospective, analytical, hospital-based study conducted in the Department of Anatomy in collaboration with the Department of Obstetrics and Gynaecology, MGM Medical College & LSK Hospital, Kishanganj, Bihar.

 

Study population: Patients who delivered or aborted a baby with a congenital anomaly during the study period were included. A total of 50 congenital abnormalities were identified among delivered babies and terminated pregnancies.

 

Data collection: Pertinent information was gathered for each case, including the mother’s age, parity, gestational age, birth weight, sex of the baby and history of consanguinity. A detailed antenatal history was recorded, including the presence of maternal disease, intake of medications, exposure to radiation and complications related to delivery. Where the patient had undergone antenatal ultrasonography (USG), the findings of the scan were documented. Each newborn and terminated foetus was examined shortly after delivery for the presence of congenital abnormalities, and the findings were correlated with the antenatal scan reports where available.

 

Statistical analysis: Data were tabulated and expressed in terms of frequency and percentage. Categorical variables were summarised in tabular form to identify the demographic pattern, mode of delivery, antenatal detection rate and associated maternal risk factors.

RESULTS

A total of 50 cases of congenital anomalies were analysed. The demographic distribution of the patients is presented in Table 1. The majority of mothers (74%) belonged to the 20–29-year age group, were multiparous (64%) and resided in rural areas (78%); nearly two-thirds (64%) were unbooked at the time of presentation.

Table 1. Demographic pattern of patients (n = 50)

Variable

N

%

Variable

N

%

Age (years) — <19

1

2

Residence — Rural

39

78

20–29

37

74

Urban

11

22

>30

12

24

Booking — Booked

18

36

Parity — Primi

18

36

Unbooked

32

64

Multi

32

64

 

Antenatal ultrasonography detected congenital anomalies in 35 (70%) of the 50 patients, while 15 (30%) had not undergone an antenatal scan during pregnancy (Table 2).

Table 2. Antenatal ultrasonographic detection of congenital anomalies

Antenatal scan finding

N

%

Patients with anomalies diagnosed on USG

35

70

Patients with anomalies not diagnosed on USG

15

30

 

The mode of delivery is summarised in Table 3. Sixteen (32%) patients underwent lower segment caesarean section (LSCS) and 18 (36%) delivered preterm; 11 (22%) cases ended in abortion.

Table 3. Mode of delivery

Mode of delivery

N

%

Abortion

11

22

Preterm delivery

18

36

Vaginal delivery

5

10

Lower segment caesarean section (LSCS)

16

32

 

The various maternal risk factors associated with congenital anomalies in the present study are detailed in Table 4. Anaemia was the most frequent risk factor (30%), followed by polyhydramnios (20%) and a history of previous caesarean section (20%).

Table 4. Associated maternal risk factors

Risk factor

N

%

Anaemia

15

30

Oligohydramnios

8

16

Polyhydramnios

10

20

Breech presentation

5

10

Twin pregnancy

5

10

Preterm delivery

28

56

Pregnancy-induced hypertension (PIH)

8

16

Rh-negative status

5

10

Previous caesarean section

10

20

Intrauterine foetal death (IUFD)

6

12

 

DISCUSSION

Congenital abnormalities are a significant health issue and account for a substantial proportion of mortality and morbidity in neonates. They affect 3–5% of live births in the United States, while the reported frequency in India is approximately 2.5%. Congenital abnormalities constitute 8–15% of perinatal deaths and 13–16% of newborn deaths in India.²⁰ The WHO defines congenital anomalies as structural or functional abnormalities, including metabolic disorders, that are evident at birth.²¹ Approximately 40–60% of congenital abnormalities have an unidentified aetiology.²²,²³

 

In the present study, 37 (74%) patients were aged 20–29 years, while 12 (24%) were over 30 years of age, and 18 (36%) were primigravida. Thirty-nine (78%) patients resided in rural areas and 32 (64%) were unbooked. Previous studies have similarly demonstrated that the incidence of congenital abnormalities is elevated among abortions and preterm deliveries, and the findings of Bhat et al. and Sachdeva et al. are consistent with those of our investigation.²⁴⁻²⁶ In our cohort, 70% of patients had defects identified on prenatal ultrasonography, whereas 15 patients had not undergone an antenatal scan. Thirty-two per cent underwent LSCS, and 36% delivered preterm. The study identified several associated risk factors—anaemia (30%), oligohydramnios (16%), polyhydramnios (20%), twins (10%), breech presentation (10%), intrauterine growth restriction (10%), previous caesarean section (20%), Rh-negative mother (10%) and pregnancy-induced hypertension (16%). A similar pattern of risk factors was reported by Gupta et al.²⁷

Congenital abnormalities are a primary cause of foetal demise, and autopsy considerably aids in the detection of intrauterine foetal death.²⁸ The family requires accurate information regarding the aetiology of foetal demise, as the couple’s future reproductive choices are contingent upon the underlying cause; this also allows prediction of recurrence risk and may help avert analogous losses in subsequent pregnancies.²⁹ Identifying defects and deformities prenatally through different investigations such as ultrasonography, chromosomal analysis, foetal autopsy and placental evaluation mitigates the chance of recurrence, which may otherwise reach 25%.³⁰

CONCLUSION

The findings of the present study indicate that congenital abnormalities were more frequent among patients from rural areas and were associated with a higher incidence of stillbirth and preterm delivery. To effectively manage this important public health problem, early diagnosis through routine prenatal ultrasonography, comprehensive antenatal care for all pregnant women—including those from rural and unbooked populations—and appropriate counselling for both the index pregnancy and any subsequent pregnancies are essential.

LIMITATIONS OF THE STUDY

The principal limitations of this study are its retrospective design, the relatively small sample size of 50 cases and the fact that it was conducted at a single tertiary care centre. Karyotyping and detailed genetic analysis could not be performed in all cases. Larger, prospective, multicentre studies incorporating cytogenetic evaluation are recommended to confirm and extend the present findings.

CONFLICT OF INTEREST

The authors declare that they have no conflict of interest.

SOURCE OF FUNDING

None.

ACKNOWLEDGEMENTS

The authors gratefully acknowledge the Department of Obstetrics and Gynaecology and the Department of Radiology, MGM Medical College & LSK Hospital, Kishanganj, for their cooperation and support in the conduct of this study.

REFERENCES

  1. Patel ZM, Adhia RA. Birth defects surveillance study. Indian J Pediatr. 2005;72(6):489–91.
  2. Kale PP, Kanetkar SR, Shukla DB, et al. Study of congenital malformations in foetal and early neonatal autopsies. Ann Pathol Lab Med. 2017;4(4):433–41.
  3. Pushpa B, Subitha S, Lokesh Kumar V. Study on various congenital anomalies in foetal autopsy. Int J Med Res Rev. 2016;4(9):1667–74.
  4. Chaturvedi P, Banerjee KS. Spectrum of congenital malformations in newborns from rural Maharashtra. Indian J Pediatr. 1989;56(4):501–7.
  5. Datta V, Chaturvedi P. Congenital malformations in rural Maharashtra. Indian Pediatr. 2000;37(9):998–1001.
  6. Grover N. Congenital malformations in Shimla. Indian J Pediatr. 2000;67(4):249–51.
  7. Taksande A, Vilhekar K, Chaturvedi P, Jain M. Congenital malformations at birth in Central India: a rural medical college hospital-based data. Indian J Hum Genet. 2010;16(3):159–63.
  8. Venkataswamy C, Gurusamy U, Lakshmi SV. Second-trimester foetal autopsy: a morphological study with prenatal USG correlations and clinical implications. J Lab Physicians. 2018;10(3):338–45.
  9. Grover S, Garg B, Sood N, Arora K. Lethal congenital malformations in foetuses—antenatal ultrasound or perinatal autopsy. Fetal Pediatr Pathol. 2017;36(3):220–31.
  10. Groisman B, Bermejo-Sánchez E, Romitti PA, Botto LD, Feldkamp ML, Walani SR, et al. Join World Birth Defects Day. Pediatr Res. 2019;86(1):3–4.
  11. Bale JR, Stoll BJ, Lucas AO, editors. Reducing birth defects: meeting the challenge in the developing world. Washington (DC): National Academies Press; 2003.
  12. World Health Organization. Birth defects: report by the Secretariat (provisional agenda item 11.7, A63/10). Geneva: Sixty-third World Health Assembly; 2010. p. 1–7.
  13. Centers for Disease Control and Prevention. World Birth Defects Day. Atlanta (GA): CDC; 2019.
  14. Howse JL, Howson CP, Katz M. Reducing the global toll of birth defects. Lancet. 2005;365(9474):1846–7.
  15. Shanmuga Priya S, Rajendiran S, Joseph LD, et al. Correlation of foetal autopsy with prenatal ultrasound findings: study in a tertiary care teaching hospital. Indian J Pathol Oncol. 2016;3(4):644–8.
  16. Venkataswamy C, Gurusamy U, Lakshmi SV. Second-trimester foetal autopsy: a morphological study with prenatal USG correlations and clinical implications. J Lab Physicians. 2018;10(3):338–45.
  17. Grover S, Garg B, Sood N, Arora K. Lethal congenital malformations in foetuses—antenatal ultrasound or perinatal autopsy. Fetal Pediatr Pathol. 2017;36(3):220–31.
  18. Long G, Sprigg A. A comparative study of routine versus selective foetal anomaly ultrasound scanning. J Med Screen. 1998;5(1):6–10.
  19. Ernst LM. A pathologist’s perspective on the perinatal autopsy. Semin Perinatol. 2015;39(1):55–63.
  20. Grover N. Congenital malformations in Shimla. Indian J Pediatr. 2000;67(4):249–51.
  21. World Health Organization. Congenital anomalies: fact sheet N° 370. Geneva: WHO; 2014.
  22. Kalter H, Warkany J. Medical progress. Congenital malformations: aetiologic factors and their role in prevention. N Engl J Med. 1983;308(8):424–31.
  23. Nelson K, Holmes LB. Malformations due to presumed spontaneous mutations in newborn infants. N Engl J Med. 1989;320(1):19–23.
  24. Bhat V, Babu L. Congenital malformations at birth—a prospective study from South India. Indian J Pediatr. 1998;65(6):873–81.
  25. Sachdeva S, Nanda S, Bhalla K, Sachdeva R. Gross congenital malformation at birth in a government hospital. Indian J Public Health. 2014;58(1):54–6.
  26. Chippa S, et al. Study of congenital anomalies during pregnancy. Int J Recent Trends Sci Technol. 2014;12(1):73.
  27. Gupta S, Gupta P, Jagdish S. Study on incidence of various systemic congenital malformations and their association with maternal factors. Natl J Med Res. 2012;2(1):19–21.
  28. Nayak SR, Garg N. Determination of antepartum foetal death. J Obstet Gynaecol India. 2010;60(6):494–7.
  29. Olsen ØE, Espeland A, Maartmann-Moe H, Lachman RS, Rosendahl K. Diagnostic value of radiography in cases of perinatal death: a population-based study. Arch Dis Child Fetal Neonatal Ed. 2003;88(6):F521–4.
  30. Boyd PA, Tondi F, Hicks NR, Chamberlain PF. Autopsy after termination of pregnancy for foetal anomaly: retrospective cohort study. BMJ. 2004;328(7432):137–40.
Recommended Articles
Research Article Open Access
Validation Of the New Ballard Score in Term Neonates in South India– A Prospective Validational Study
2026, Volume-7, Issue 3 : 1080-1091
Research Article Open Access
Her2/Neu Immunoexpression in Primary Breast Carcinoma and its Correlation with Er/Pr Status and Various Clinicopathological Features
2026, Volume-7, Issue 3 : 1073-1079
Research Article Open Access
Ultrasonographic Comparative Study of Head Circumference In Fetuses of North Indian Women
2026, Volume-7, Issue 3 : 1058-1063
Research Article Open Access
Aerobic Bacterial Profile and Antibiogram of Pus Isolates: A Six-Month Retrospective Study in a Tertiary Care Teaching Hospital, Krishnagiri, Tamil Nadu
2026, Volume-7, Issue 3 : 1092-1097
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 3
Citations
17 Views
13 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved